| Bioactivity | Rivabazumab is a recombinant antibody against Pseudomonas aeruginosa pcrV[1]. |
| Name | Rivabazumab |
| CAS | 1627519-84-9 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wenshe Ray LIU, et al. Protease switch for dual targets chimeric antigen receptor t cell therapy. WO2021087245. |